The Synthetic-Technical Development of Oseltamivir Phosphate Tamiflu™: A Race against Time

The clinical development of the first orally available neuraminidase inhibitor prodrug oseltamivir phosphate (Tamiflu™) proceeded very fast. In order to support this program an unprecedented team effort in chemical process research, development, piloting, production and analytics took plac...

Full description

Bibliographic Details

Published in:	CHIMIA
Main Authors:	Stefan Abrecht, René Trussardi, Gösta Rimmler, Thomas Oberhauser, Hans-Jürgen Mair, Martin Karpf, Rolf Fischer, Heinrich Estermann, Muriel Cordon Federspiel, Ulrich Zutter
Format:	Article
Language:	German
Published:	Swiss Chemical Society 2007-03-01
Subjects:	Analytics Influenza neuraminidase inhibitor Oseltamivir phosphate Production Synthesis Technical development
Online Access:	https://chimia.ch/chimia/article/view/4283